Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Clinical Research Article
  • Published:

Inflammation induces stunting by lowering bone mass via GH/IGF-1 inhibition in very preterm infants

Abstract

Background

Sustained systemic inflammatory response (SIR) was associated with poor postnatal growth in very preterm infants (VPI). We hypothesize that VPI with sustained SIR will exhibit linear growth retardation related to lower bone mass accrual mediated by GH/IGF-1 axis inhibition at term corrected age (CA).

Methods

C-reactive protein (CRP), procalcitonin (PCT), growth hormone (GH), insulin-like growth factor 1 (IGF-1), calcium, phosphorus, alkaline phosphatase, anthropometric, nutritional, neonatal and maternal data were collected prospectively in 23 infants <32 weeks gestational age. Body composition using dual-energy X-ray absorptiometry was performed at term CA. Analysis was undertaken with multiple linear regression models.

Results

At term CA 11 infants with sustained SIR compared with 12 infants without sustained SIR present significantly lower IGF-1, length z-score (LZS), bone mineral content (BMC) and lean mass (LM), and higher GH and fat mass (FM). LZS was associated significantly with PCT, BMC with IGF-1, FM and LM with CRP, GH with bronchopulmonary dysplasia and CRP, and IGF-1 with invasive mechanical ventilation, CRP and PCT.

Conclusions

In addition to the known effect on linear growth failure, sustained SIR induces lower bone mass accrual related to higher GH and lower IGF-1 levels in VPI.

Impact

  • Very preterm infants (VPI) with sustained systemic inflammatory response (SIR) compared with VPI without SIR present stunting, lower bone mass, higher GH and lower IGF-1 levels at term corrected age.

  • SIR may help to explain the influence of non-nutritional factors on growth and body composition in VPI.

  • SIR induces postnatal stunting related to lower bone mass accrual via GH/IGF-1 axis inhibition in VPI.

  • VPI with SIR need special attention to minimize inflammatory stress, which could result in improved postnatal growth.

  • Research on inflammatory-endocrine interactions involved in the pathophysiology of postnatal stunting is needed as a basis for new interventional approaches.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Flowchart of sample size.
Fig. 2: Explanatory model of the effect of inflammation on the regulation of the growth hormone/insulin-like growth factor 1 axis.

Similar content being viewed by others

Data availability

The datasets generated during the present study are available to others upon reasonable request via email to the corresponding author.

References

  1. Johnson, L., Llewellyn, C. H., van Jaarsveld, C. H. M., Cole, T. J. & Wardle, J. Genetic and environmental influences on infant growth: prospective analysis of the gemini twin birth cohort. PLoS One 6, e19918 (2011).

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Young, A., Beattie, R. M. & Johnson, M. J. Optimising growth in very preterm infants: reviewing the evidence. Arch. Dis. Child. Fetal Neonatal Ed. 108, 2–9. https://doi.org/10.1136/archdischild-2021-322892 (2023).

  3. Möllers, L. S. et al. Metabolic-endocrine disruption due to preterm birth impacts growth, body composition, and neonatal outcome. Pediatr. Res. 91, 1350–1360 (2022).

    PubMed  Google Scholar 

  4. Maitre, L. et al. Human Early Life Exposome (HELIX) study: a European population-based exposome cohort. BMJ Open 8, e021311 (2018).

    PubMed  PubMed Central  Google Scholar 

  5. Cuestas, E. et al. Socioeconomic inequalities in low birth weight risk before and during the COVID-19 pandemic in Argentina: a cross-sectional study. Lancet Reg. Health Am. 2, 100049 (2021).

    PubMed  PubMed Central  Google Scholar 

  6. Manzar, S. Poor postnatal growth in preterm infants. Acta Paediatr. 111, 1458 (2022).

  7. Ramel, S. E. et al. The relationship of poor linear growth velocity with neonatal illness and two-year neurodevelopment in preterm infants. Neonatology 102, 19–24 (2012).

    PubMed  Google Scholar 

  8. Morgan, A. S., Mendonça, M., Thiele, N. & David, A. L. Management and outcomes of extreme preterm birth. BMJ 376, e055924 (2022).

    PubMed  PubMed Central  Google Scholar 

  9. Lucaccioni, L., Iughetti, L., Berardi, A. & Predieri, B. Challenges in the growth and development of newborns with extra-uterine growth restriction. Expert Rev. Endocrinol. Metab. 17, 415–423 (2022).

    CAS  PubMed  Google Scholar 

  10. Cuestas, E., Aguilera, B., Cerutti, M. & Rizzotti, A. Sustained neonatal inflammation is associated with poor growth in infants born very preterm during the first year of life. J. Pediatr. 205, 91–97 (2019).

    PubMed  Google Scholar 

  11. Synnes, A. & Hicks, M. Neurodevelopmental outcomes of preterm children at school age and beyond. Clin. Perinatol. 45, 393–408 (2018).

    PubMed  Google Scholar 

  12. Bavineni, M. et al. Mechanisms linking preterm birth to onset of cardiovascular disease later in adulthood. Eur. Heart J. 40, 1107–1112 (2019).

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Forbes, G. B. Relation of lean body mass to height in children and adolescents. Pediatr. Res. 6, 32–37 (1972).

    CAS  PubMed  Google Scholar 

  14. Belfort, M. B. et al. Systemic inflammation in the first 2 weeks after birth as a determinant of physical growth outcomes in hospitalized infants with extremely low gestational age. J. Pediatr. 240, 37–43.e1 (2022).

    CAS  PubMed  Google Scholar 

  15. Pfister, K. M. & Ramel, S. E. Linear growth and neurodevelopmental outcomes. Clin. Perinatol. 41, 309–321 (2014).

    PubMed  Google Scholar 

  16. Bell, K. A. et al. Body composition measurement for the preterm neonate: using a clinical utility framework to translate research tools into clinical care. J. Perinatol. 42, 1550–1555 https://doi.org/10.1038/s41372-022-01529-9 (2022).

  17. DeBoer, M. D. et al. Mice with infectious colitis exhibit linear growth failure and subsequent catch-up growth related to systemic inflammation and IGF-1. Nutr. Res. 39, 34–42 (2017).

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Cirillo, F., Lazzeroni, P., Sartori, C. & Street, M. E. Inflammatory diseases and growth: effects on the GH–IGF axis and on growth plate. Int. J. Mol. Sci. 18, 1878 (2017).

    PubMed  PubMed Central  Google Scholar 

  19. DeBoer, M. D. et al. Systemic inflammation, growth factors, and linear growth in the setting of infection and malnutrition. Nutrition 33, 248–253 (2017).

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Villar, J. et al. INTERGROWTH-21st very preterm size at birth reference charts. Lancet 387, 844–845 (2016).

    PubMed  Google Scholar 

  21. Villar, J. et al. Postnatal growth standards for preterm infants: the Preterm Postnatal Follow-up Study of the INTERGROWTH-21(st) Project. Lancet Glob. Health 3, e681–e691 (2015).

    PubMed  Google Scholar 

  22. Mazess, R. B., Barden, H. S., Bisek, J. P. & Hanson, J. Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am. J. Clin. Nutr. 51, 1106–1112 (1990).

    CAS  PubMed  Google Scholar 

  23. Godang, K. et al. Assessing body composition in healthy newborn infants: reliability of dual-energy x-ray absorptiometry. J. Clin. Densitom. 13, 151–160 (2010).

    PubMed  Google Scholar 

  24. ICD-10 Version. https://icd.who.int/browse10/2016/en#/ (2016).

  25. Bell, M. J. et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann. Surg. 187, 1–7 (1978).

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Ehrenkranz, R. A. et al. Growth in the neonatal intensive care unit influences neurodevelopmental and growth outcomes of extremely low birth weight infants. Pediatrics 117, 1253–1261 (2006).

    PubMed  Google Scholar 

  27. Papile, L. A., Burstein, J., Burstein, R. & Koffler, H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J. Pediatr. 92, 529–534 (1978).

    CAS  PubMed  Google Scholar 

  28. Chiang, M. F. et al. International Classification of Retinopathy of Prematurity, Third Edition. Ophthalmology 128, e51–e68 (2021).

    PubMed  Google Scholar 

  29. American Academy of Pediatrics. Committee on Nutrition. Nutritional needs of the preterm infant. In Pediatric Nutrition 8th edn (eds Kleinman, R. E. & Greer, F. R.) 113–162 (American Academy of Pediatrics, 2019).

  30. Champely, S. et al. pwr: Basic Functions for Power Analysis (2020).

  31. Kim, S. ppcor: an R package for a fast calculation to semi-partial correlation coefficients. Commun. Stat. Appl. Methods 22, 665–674 (2015).

    PubMed  PubMed Central  Google Scholar 

  32. Jafari, M. & Ansari-Pour, N. Why, when and how to adjust your P values?. Cell J. 20, 604–607 (2019).

    PubMed  Google Scholar 

  33. Kumar, P. & Seshadri, R. Neonatal morbidity and growth in very low birth-weight infants after multiple courses of antenatal steroids. J. Perinatol. 25, 698–702 (2005).

    PubMed  Google Scholar 

  34. McElrath, T. F. et al. Pregnancy disorders that lead to delivery before the 28th week of gestation: an epidemiologic approach to classification. Am. J. Epidemiol. 168, 980–989 (2008).

    CAS  PubMed  PubMed Central  Google Scholar 

  35. Chisholm, K. M., Norton, M. E., Penn, A. A. & Heerema-McKenney, A. Classification of preterm birth with placental correlates. Pediatr. Dev. Pathol. 21, 548–560 (2018).

    PubMed  Google Scholar 

  36. Mestan, K. et al. Placental inflammatory response is associated with poor neonatal growth: preterm birth cohort study. Pediatrics 125, e891–898 (2010).

    PubMed  Google Scholar 

  37. Scharf, R. J., Stroustrup, A., Conaway, M. R. & DeBoer, M. D. Growth and development in children born very low birthweight. Arch. Dis. Child. Fetal Neonatal Ed. 101, F433–F438 (2016).

    PubMed  Google Scholar 

  38. Ballinger, A. B., Azooz, O., El-Haj, T., Poole, S. & Farthing, M. J. Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis. Gut 46, 694–700 (2000).

    CAS  PubMed  PubMed Central  Google Scholar 

  39. Zemel, B. S. et al. Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children. J. Clin. Endocrinol. Metab. 95, 1265–1273 (2010).

    CAS  PubMed  PubMed Central  Google Scholar 

  40. Heaney, R. P. Bone mineral content, not bone mineral density, is the correct bone measure for growth studies. Am. J. Clin. Nutr. 78, 350–351 (2003).

    CAS  PubMed  Google Scholar 

  41. Mølgaard, C., Thomsen, B. L., Prentice, A., Cole, T. J. & Michaelsen, K. F. Whole body bone mineral content in healthy children and adolescents. Arch. Dis. Child. 76, 9–15 (1997).

    PubMed  PubMed Central  Google Scholar 

  42. Magnusson, A., Swolin-Eide, D. & Elfvin, A. Body composition and bone mass among 5-year-old survivors of necrotizing enterocolitis. Pediatr. Res. https://doi.org/10.1038/s41390-022-02236-z (2022).

  43. Vohlen, C. et al. Dynamic regulation of GH-IGF1 signaling in injury and recovery in hyperoxia-induced neonatal lung injury. Cells 10, 2947 (2021).

    CAS  PubMed  PubMed Central  Google Scholar 

  44. Blair, C. et al. Liver IGF-1 mRNA expression is decreased by mechanical ventilation of preterm lambs. J. Investig. Med. 58, 105–105 (2010).

    Google Scholar 

  45. Löfqvist, C. et al. Low postnatal serum IGF-I levels are associated with bronchopulmonary dysplasia (BPD). Acta Paediatr. 101, 1211–1216 (2012).

    PubMed  PubMed Central  Google Scholar 

  46. DeBoer, M. D. & Denson, L. A. Delays in puberty, growth, and accrual of bone mineral density in pediatric Crohn’s disease: despite temporal changes in disease severity, the need for monitoring remains. J. Pediatr. 163, 17–22 (2013).

    PubMed  PubMed Central  Google Scholar 

  47. Wong, S. C. et al. Growth and the growth hormone-insulin like growth factor 1 axis in children with chronic inflammation: current evidence, gaps in knowledge, and future directions. Endocr. Rev. 37, 62–110 (2016).

    CAS  PubMed  Google Scholar 

  48. Kubicky, R. A., Wu, S., Kharitonenkov, A. & De Luca, F. Role of fibroblast growth factor 21 (FGF21) in undernutrition-related attenuation of growth in mice. Endocrinology 153, 2287–2295 (2012).

    CAS  PubMed  Google Scholar 

  49. Misra, M. et al. Alterations in growth hormone secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J. Clin. Endocrinol. Metab. 88, 5615–5623 (2003).

    CAS  PubMed  Google Scholar 

  50. Yumani, D. F. J., Calor, A. K. & van Weissenbruch, M. M. The course of IGF-1 levels and nutrient intake in extremely and very preterm infants during hospitalisation. Nutrients 12, 675 (2020).

    CAS  PubMed  PubMed Central  Google Scholar 

  51. Cooke, R. J. & Griffin, I. Altered body composition in preterm infants at hospital discharge. Acta Paediatr. 1992 98, 1269–1273 (2009).

    Google Scholar 

  52. Tremblay, G. et al. Body composition in very preterm infants: role of neonatal characteristics and nutrition in achieving growth similar to term infants. Neonatology 111, 214–221 (2017).

    CAS  PubMed  Google Scholar 

  53. Moldawer, L. L. & Copeland, E. M. Proinflammatory cytokines, nutritional support, and the cachexia syndrome: interactions and therapeutic options. Cancer 79, 1828–1839 (1997).

    CAS  PubMed  Google Scholar 

  54. Roubenoff, R. Inflammatory and hormonal mediators of cachexia. J. Nutr. 127, 1014S–1016S (1997).

    CAS  PubMed  Google Scholar 

  55. Giannì, M. L. et al. Adiposity in small for gestational age preterm infants assessed at term equivalent age. Arch. Dis. Child Fetal Neonatal Ed. 94, F368–F372 (2009).

    PubMed  Google Scholar 

  56. Sauer, P. J. J. Can extrauterine growth approximate intrauterine growth? Should it? Am. J. Clin. Nutr. 85, 608S–613S (2007).

    CAS  PubMed  Google Scholar 

  57. Sethi, J. K. & Vidal-Puig, A. J. Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J. Lipid Res. 48, 1253–1262 (2007).

    CAS  PubMed  Google Scholar 

  58. Ramel, S. E. et al. Body composition changes in preterm infants following hospital discharge: comparison with term infants. J. Pediatr. Gastroenterol. Nutr. 53, 333–338 (2011).

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors thank Nicholas Basily for editing the English language of this manuscript.

Funding

This study was supported by the Agencia Nacional de Promoción Científica y Tecnológica (FONCYT) grant PICT 2019-3062.

Author information

Authors and Affiliations

Authors

Contributions

E.C. conceptualized and designed the study, coordinated and supervised data collection, carried out the final data analyses, drafted the manuscript, and reviewed and revised the final manuscript. M.H., S.G., M.I.G., V.S. and A.R. designed the data collection instruments, manually collected data, carried out the initial analyses, and reviewed and revised the manuscript for important intellectual content. All authors have approved the final manuscript as submitted.

Corresponding author

Correspondence to Eduardo Cuestas.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval and consent to participate

The study was approved by the Institutional Review Board at Hospital Privado Universitario de Córdoba, and the infants’ parents gave written informed consent (HP 4-308). This study used anonymized and deidentified data, fulfilling local data protection regulations.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cuestas, E., Hillman, M., Galetto, S. et al. Inflammation induces stunting by lowering bone mass via GH/IGF-1 inhibition in very preterm infants. Pediatr Res 94, 1136–1144 (2023). https://doi.org/10.1038/s41390-023-02559-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41390-023-02559-5

Search

Quick links